ClinicalTrials.gov
public full text
Public Domain
Curcumin as a Novel Treatment to Improve Cognitive Dysfunction in Schizophrenia
The investigators propose to test whether curcumin nanoparticles will improve behavioral measures and biomarkers of cognition and neuroplasticity in patients with schizophrenia who are already receiving a stable dose of antipsychotic.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Bioengineered curcumin-SCFA co-loaded PLGA nanoparticles for modulating inflammation and epithelial barrier integrity in radiation-induced enteritis.#162028
- Clinical innovations and future directions of nanoparticles in the treatment of psychiatric and neurological disorders#651743
- Clinical innovations and future directions of nanoparticles in the treatment of psychiatric and neurological disorders#431858
- Curcumin and piperine in neurodegenerative disorders: a systematic review of preclinical neuroprotective evidence.#399624
- Berberine in Treating Negative Symptoms of Schizophrenia: Clinical Efficacy and Mechanisms#826107
Record · ID 1395681
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive